Bioactive Materials Market size is estimated to be valued at USD 2,903.4 Mn in 2025 and is expected to reach USD 7,606.3 Mn in 2032, exhibiting a compound annual growth rate (CAGR) of14.75% from 2025 to 2032.
Increasing investments in the healthcare system, together with technological advancements in medicine, are driving robust growth in the global bioactive materials market. Other factors improving Bioactive Materials Market Growth include the rising number of knee replacement procedures and improvements in surgical methods. Applications in orthopedics and wounds are increasingly employing bioactive materials, as these materials are helpful in healing and patient's recovery processes. Especially important is the role of bioactive materials in the creation of sophisticated biomaterials for surgical instruments and dressings for tissue regeneration.
|
Event |
Description and Impact |
|
Advancements in Tissue Engineering and Regenerative Medicine |
|
|
Growing Demand for Dental and Orthopedic Implants |
|
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Repairing tissue injuries with bioactive substances is becoming more common owing to their bioactivity in the organism and bioactive glass’s 34.8% market share for the forecast period proves just that. It’s the market leader because of its tremendous scope in promoting healing through aiding restoration activities, while surgeries are strengthening the need for rapid-cure surgical interventions. All these factors placed bioactive materials at the forefront.
In addition, bioactive glasses are used in a wide range of disciplines addressing transformation processes. Bioactive ceramics offer high biocompatibility and excellent durability making them the best choice for various medical applications causing substantial growth in demand of these materials in the medical sector promoting restoration to organs.
By Application, Dental Care segment is estimated to remain the largest share throughout the anticipated period. Bioactive materials are used in conservative dentistry for root canal therapy, regeneration of tooth tissues, implantation and reconstruction as well as repair of various dental structures.
The Other Applications segment is expected to be highly profitable owing to the increased use of bioactive materials for orthopedic and cosmetic surgeries. These materials aid in bone grafting, strengthening soft tissues, and cell therapy, thereby enhancing many surgical procedures, are one of the reasons for the growth in Bioactive Materials Market Forecast.
To learn more about this report, Download Free Sample
The steadily adopting biomaterials, robust healthcare systems, and active R&D investment alongside expanding healthcare services in the region is expected to keep North America on top with a market share of 43.32% in 2025. Some key players in the industry include Stryker Corporation, Medtronic, and Zimmer Biomet who are actively developing new biomaterials for surgical implants, orthopedics, tissue engineering, and advanced wound care.
The rising demand for bioactively synthesized materials due to acceleration in skeletal disorders, chronic diseases, and aging population also supports the Bioactive Materials Market Outlook
along with precured policies focused on innovation and performance in healthcare from the U.S. and Canada.
Investment towards regenerative and personalized medicine alongside government funding towards innovative biotechnology is premised to assist Europe in capturing a market share of 23.12% by 2025. Market players such as Royal DSM, BASF, and Bio-Techne are active in the region and are producing bioactive materials for tissue regeneration, orthopedic implants, and drug delivery systems.
Also, noteworthy are the advanced healthcare systems Germany has that alongside precision medicine makes them a European leader in the bioactive materials market. This region of Europe will continue to expand due to the strong regional regulatory frameworks, supportive government policies, clinical study investment, and extensive research advancement from the private sector.
The Bioactive Materials Market Value is growing rapidly in the Asia-Pacific region and is expected to reach a 17.30% market share by 2025. This is attributable to an increase in investment in healthcare, medical tourism, and awareness of bioactive solutions in China, India, and Japan. Demand for sophisticated biomaterials for use in orthopedic surgery, dental implants, and wound healing, along with the developing healthcare infrastructure of the region, are also factors contributing to market growth.
Moreover, investment for the development and application of bioactive materials, especially in regenerative medicine and tissue engineering, is growing in this region due to government incentives and collaborations with international biotech companies.
The bioactive materials market in U.S.A continues to be one of the most significant markets due to the continuous technological changes and a sustained level of public and private expenditure on healthcare and biotechnology. The Bioactive Materials Market demand is expanding as technologically advanced firms such as Johnson & Johnson, Medtronic, and NuVasive are Biologics of medical implants, bone regeneration, and advanced wound care bioactive materials are formulated and developed by the industry.
As the population progressively ages, the healthcare needs will rise, which will enable further expansion of the bioactive materials market in advanced, biocompatible materials for medical use in the country.
The bioactive materials markets in India is gaining noteworthy attention across the world due to new government initiatives towards biotechnology and improvement of the healthcare facilities. India is trying to emerge as a global leader with companies like Premas Life Sciences and Hindustan Biotech stepping forward for the development of medical devices and implantable bioactive materials.
Significant work being done in R&D pertaining to improved access to healthcare services in orthopedics, dental care, and pediatrics is also fueling in-country consumption of bioactive materials.
Supported by an ever-growing demand for advanced biological treatment and therapeutics, China's bio-active material market is rapidly expanding due to initiatives funded by the government to support research, biotechnology, and healthcare. BGI Group and Shanghai Biomaterials are among market leaders who are applying bioactive materials to clinical setting in the form of orthopedic implants and tissue engineering.
Fostering healthcare innovation under the banner of “Made in China 2025” is bound to contribute further Bioactive materials demand making China stand out as one of the most advanced markets in the world.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2,903.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 14.75% | 2032 Value Projection: | USD 7,606.3 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Arthrex Inc, Bioactive Bone Substitutes OyJ, Biomatlante, DSM, Cam Bioceramics, Ceraver, DePuy Synthes (Johnson and Johnson), Medtronic Inc., Noraker, Pulpdent Corporation, Septodont Holding, Stryker Corporation, Zimmer Holdings Inc, Collagen Matrix Inc., OSARTIS GmbHm, Evonik Industries AG, and Boston Scientific Corporation |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Uncover macros and micros vetted on 75+ parameters: Get instant access to report
Advancement in technology has led to the development of bioengineering and tissues engineering techniques. Moreover, ongoing development on novel drug delivery technologies have further boosted market growth. For instance, in January 2019, DSM Biomedical partnered with ProMed Pharma to leverage its biomedical biomaterials with ProMed’s micro molding and extrusion capabilities to create novel controlled-release drug implants and combination devices.
Porous-coated and fully porous orthopedic implants are becoming more popular in total ankle replacement surgery. This is mainly due to the improved osseointegration of these implants. Moreover, the use of this coating on the osseous interface of the implant increases the chances of survivorship.
These coatings are made of shape memory material that expands once the implant is inserted into the bone. The interconnected networks of pores of the porous surface coats are infiltrated with bone promoting agents. Hence, advent of biomaterials will positively impact the market growth.
Portland cement or mineral trioxide aggregate (MTA) is a bioactive material that is widely used in the root canal therapy. It is used for maintaining pulp and periodontal tissue vitality as part of pulp capping and perforation repair procedures. Moreover, dentin extracellular matrix proteins (ECMPs) are also important bioactive materials, contain growth factors which can uphold pulp regeneration and tooth healing.
The Global Burden of Disease Study 2019 estimated that oral diseases affect close to 3.5 billion people worldwide. Globally, it is estimated that 2 billion people suffer from caries of permanent teeth and 520 million children suffer from caries of primary teeth.
Bioactive materials have a great potential for improving the quality of life. They help to suppress the immune system, improve tissue regeneration, and promote bone growth. A number of polymer-based bioactive materials exhibit osteoconductive properties. Collagen fibrin, hyaluronic acid, and chitosan are some examples.
The emergence of technologically advanced medical devices has provide significant growth opportunities for the global bioactive materials market. Recent research has investigated how these devices modulate biological activity. These studies have been carried out to determine the potential of bioactive materials in promoting tissue regeneration and maintaining the health of patients.
Increased prevalence of arthritis among the elderly population is a major factor expected to bring bright market opportunities. Moreover, the growing age group has also resulted in increased number of surgeries for joint replacement. Besides, the increasing usage of bioactive materials in the pharmaceutical and cosmetic industries is also driving growth of the market.
According to OCED data, in 2020, the total number of knee replacements in Canada stood at 198.4 per 100,000 inhabitants, which are increasing annually at a high rate with the rising old generation and increasing arthritis problem in the region.
*Definition: Bioactive materials are used in the pharmaceutical and medical industries. These materials are designed to interact with the physiological fluids in the human body. They act as a carrier for the transport of these fluids
Share
Share
About Author
Yash Doshi is a Senior Management Consultant. He has 12+ years of experience in conducting research and handling consulting projects across verticals in APAC, EMEA, and the Americas.
He brings strong acumen in helping chemical companies navigate complex challenges and identify growth opportunities. He has deep expertise across the chemicals value chain, including commodity, specialty and fine chemicals, plastics and polymers, and petrochemicals. Yash is a sought-after speaker at industry conferences and contributes to various publications on topics related commodity, specialty and fine chemicals, plastics and polymers, and petrochemicals.
Missing comfort of reading report in your local language? Find your preferred language :
Transform your Strategy with Exclusive Trending Reports :
Frequently Asked Questions
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
Schedule a meeting with report Author
